Lior Soussan‐Gutman

2.9k total citations
41 papers, 1.0k citations indexed

About

Lior Soussan‐Gutman is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lior Soussan‐Gutman has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cancer Research, 20 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lior Soussan‐Gutman's work include Cancer Genomics and Diagnostics (17 papers), Lung Cancer Treatments and Mutations (12 papers) and Breast Cancer Treatment Studies (10 papers). Lior Soussan‐Gutman is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Lung Cancer Treatments and Mutations (12 papers) and Breast Cancer Treatment Studies (10 papers). Lior Soussan‐Gutman collaborates with scholars based in Israel, United States and France. Lior Soussan‐Gutman's co-authors include Addie Dvir, Vincent A. Miller, Nir Peled, Noa Ben-Baruch, Shulamith Rizel, Maya Ilouze, David Sarid, Roman Yelensky, Keren Merenbakh-Lamin and Ido Wolf and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Lior Soussan‐Gutman

37 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lior Soussan‐Gutman Israel	16	526	509	500	300	242	41	1.0k
John Jiang United States	12	725 1.4×	614 1.2×	505 1.0×	458 1.5×	176 0.7×	17	1.2k
Atocha Romero Spain	20	567 1.1×	767 1.5×	453 0.9×	612 2.0×	135 0.6×	66	1.4k
Elisha Hughes United States	15	524 1.0×	375 0.7×	207 0.4×	521 1.7×	498 2.1×	38	1.1k
Christina I. Herold United States	11	770 1.5×	461 0.9×	264 0.5×	388 1.3×	325 1.3×	26	1.3k
Adriana López‐Doriga Spain	13	456 0.9×	290 0.6×	236 0.5×	358 1.2×	158 0.7×	24	938
Zaina Sangale United States	15	432 0.8×	483 0.9×	711 1.4×	510 1.7×	119 0.5×	32	1.2k
Guochun Zhang China	19	572 1.1×	525 1.0×	478 1.0×	456 1.5×	60 0.2×	62	1.1k
Aiko Sueta Japan	18	340 0.6×	487 1.0×	185 0.4×	455 1.5×	157 0.6×	45	947
Sandra E. Edwards United Kingdom	12	307 0.6×	430 0.8×	653 1.3×	690 2.3×	223 0.9×	15	1.2k
Jacqui Rowbottom United Kingdom	10	1.2k 2.3×	321 0.6×	791 1.6×	567 1.9×	215 0.9×	14	1.6k

Countries citing papers authored by Lior Soussan‐Gutman

Since Specialization

Citations

This map shows the geographic impact of Lior Soussan‐Gutman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lior Soussan‐Gutman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lior Soussan‐Gutman more than expected).

Fields of papers citing papers by Lior Soussan‐Gutman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lior Soussan‐Gutman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lior Soussan‐Gutman. The network helps show where Lior Soussan‐Gutman may publish in the future.

Co-authorship network of co-authors of Lior Soussan‐Gutman

This figure shows the co-authorship network connecting the top 25 collaborators of Lior Soussan‐Gutman. A scholar is included among the top collaborators of Lior Soussan‐Gutman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lior Soussan‐Gutman. Lior Soussan‐Gutman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hubert, Ayala, Sofia Man, Ravit Geva, et al.. (2024). Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data. ESMO Open. 9(8). 103648–103648. 1 indexed citations

Yerushalmi, Rinat, Shani Paluch–Shimon, Lior Soussan‐Gutman, et al.. (2024). BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization. Breast Cancer Research and Treatment. 206(1). 67–76.

Brenner, Baruch, Ayala Hubert, Sofia Man, et al.. (2023). Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.. Journal of Clinical Oncology. 41(16_suppl). 3620–3620.

Shachar, Shlomit Strulov, Michelle Leviov, Rinat Yerushalmi, et al.. (2023). Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry. npj Breast Cancer. 9(1). 79–79. 1 indexed citations

Leviov, Michelle, Iryna Kuchuk, Shani Paluch–Shimon, et al.. (2023). Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study. npj Breast Cancer. 9(1). 49–49.

Kian, Waleed, Amir Onn, Jair Bar, et al.. (2022). Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing. Frontiers in Oncology. 12. 912801–912801. 6 indexed citations

Roisman, Laila C., Waleed Kian, Julia Dudnik, et al.. (2021). The impact of osimertinib’ line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance. Lung Cancer. 153. 126–133. 16 indexed citations

Peled, Michael, Jair Bar, Sumit Chatterji, et al.. (2020). Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case Series.. PubMed. 22(12). 784–787. 2 indexed citations

Stemmer, Salomon M., Mariana Steiner, Shulamith Rizel, et al.. (2019). Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. npj Breast Cancer. 5(1). 41–41. 23 indexed citations

10.

Ben‐Aharon, Irit, Tal Goshen‐Lago, Ravit Geva, et al.. (2017). Sidedness matters: Surrogate biomarkers prognosticate colorectal cancer upon anatomic location.. Journal of Clinical Oncology. 35(4_suppl). 523–523. 1 indexed citations

11.

Ilouze, Maya, Laila C. Roisman, Addie Dvir, et al.. (2017). P2.03b-047 The Clinical Impact of Multiplex ctDNA Gene Analysis in Lung Cancer. Journal of Thoracic Oncology. 12(1). S964–S964. 1 indexed citations

12.

Stemmer, Salomon M., Shulamit Rizel, Tamar Peretz, et al.. (2016). First prospectively-designed outcome study in estrogen receptor (ER)+ breast cancer (BC) patients (pts) with N1mi or 1-3 positive nodes in whom treatment decisions in clinical practice incorporated the 21-gene recurrence score (RS) result. Annals of Oncology. 27. vi44–vi44. 3 indexed citations

13.

Stemmer, Salomon M., Shulamith Rizel, Lior Soussan‐Gutman, et al.. (2016). Abstract P5-08-02: Real-life analysis evaluating 1594 N0/Nmic breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score result: 5-year KM estimate for breast cancer specific survival with recurrence score results ≤30 is >98%. Cancer Research. 76(4_Supplement). P5–8. 15 indexed citations

14.

Brenner, Baruch, Ravit Geva, Megan Rothney, et al.. (2015). Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients. Value in Health. 19(1). 82–87. 13 indexed citations

15.

Epelbaum, Ron, Einat Shacham‐Shmueli, Baruch Klein, et al.. (2015). Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study. BioMed Research International. 2015. 1–9. 7 indexed citations

16.

Cherny, Nathan I., Elisabeth G.E. de Vries, Linda L. Emanuel, et al.. (2014). Words Matter: Distinguishing "Personalized Medicine" and "Biologically Personalized Therapeutics". JNCI Journal of the National Cancer Institute. 106(12). dju321–dju321. 17 indexed citations

17.

Stemmer, Salomon M., Shmuel Klang, Noa Ben-Baruch, et al.. (2013). The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients. Breast Cancer Research and Treatment. 140(1). 83–92. 34 indexed citations

18.

Merenbakh-Lamin, Keren, Noa Ben-Baruch, Adva Yeheskel, et al.. (2013). D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer. Cancer Research. 73(23). 6856–6864. 290 indexed citations

19.

Peled, Nir, Gary A. Palmer, Fred R. Hirsch, et al.. (2012). Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(9). e14–e16. 102 indexed citations

20.

Soussan‐Gutman, Lior, et al.. (2004). Interleukin‐18 is High in the Serum of IVF Pregnancies with Ovarian Hyperstimulation Syndrome*. American Journal of Reproductive Immunology. 51(5). 381–384. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact